Physician profile
David P Murphy
NPI 1184695041
$494.33
in general payments reported to CMS, 2019-2025
8 companies · $62.99 in 2025
The $62.99 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.89 · 2020: $37.68 · 2021: $41.77 · 2022: $75.95 · 2023: $181 · 2024: $57.24 · 2025: $62.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $181 · Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $180.81 |
| Food and Beverage | $120.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $145.51 | 2022-2023 | |
| Calyxo, INC. | $105.31 | 2024-2025 | Cvac Aspiration System |
| Regeneron Healthcare Solutions, INC. | $80.86 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $68.10 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $37.68 | 2020 | |
| Rochester Medical Corporation | $30.39 | 2022 | |
| Teleflex LLC | $14.92 | 2024 | Urolift |
| Astrazeneca Pharmaceuticals LP | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.